Skip to main content

Table 3 Laboratory data after IVIG treatment

From: Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study

 

Dilation group (N = 413)

Aneurysm group (N = 51)

P value

White blood count (109/L)

8.4 (6.6–10.6)

8.0 (5.4–10.9)

0.741

Haemoglobin (g/L)

107.3 ± 10.9

109.3 ± 11.9

0.258

Haematocrit (%)

0.33 (0.31–0.35)

0.33 (0.31–0.35)

0.474

Platelet count (109/L)

555.0 ± 189.7

517.1 ± 173.5

0.150

Neutrophil count (109/L)

3.3 ± 2.3

4.7 ± 6.5

0.132

C-reactive protein (mg/L)

8.7 (5.0–16.0)

8.0 (4.0–17.4)

0.364

Alanine aminotransferase (U/L)

29.0 (20.0–48.0)

34.0 (23.5–505.5)

0.730

Aspartate aminotransferase (U/L)

46.0 (38.0–61.0)

45.0 (37.5–66.5)

0.418

Albumin (g/L)

35.6 ± 4.0

34.9 ± 5.2

0.338

Brain natriuretic peptide (pg/mL)

231 (159–336)

278 (201–441)

0.143

  1. Data are shown as mean ± standard deviation or median (interquartile range)
  2. Abbreviation: IVIG intravenous immunoglobulin